RxDoctor Payments Data

Rashid Khairi

Endocrinology, Diabetes & Metabolism · Indianapolis, INNPI 1578586681

Payments from drug & device makers

$2,047in general payments, 2019–2025

Across 156 payments — averaging $13.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amneal Pharmaceuticals LLC$250
  • Novo Nordisk$236
  • AstraZeneca$221
  • Antares Pharma, Inc.$178
  • Mannkind Corporation$165
  • Sanofi-aventis U.S. LLC$153
  • plus $844 from 18 others

What the payments were for

  • Food & beverage$2,039100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,047 in reported general payments places this provider in the 50th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.

See all endocrinology, diabetes & metabolism providers in Indiana

Other endocrinology, diabetes & metabolism in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →